97 related articles for article (PubMed ID: 23871415)
1. Sirtuin-3 (SIRT3) expression is associated with overall survival in esophageal cancer.
Zhao Y; Yang H; Wang X; Zhang R; Wang C; Guo Z
Ann Diagn Pathol; 2013 Dec; 17(6):483-5. PubMed ID: 23871415
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxy-2'-deoxyguanosine expression predicts outcome of esophageal cancer.
He H; Zhao Y; Wang N; Zhang L; Wang C
Ann Diagn Pathol; 2014 Dec; 18(6):326-8. PubMed ID: 25240715
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Yan SM; Han X; Han PJ; Chen HM; Huang LY; Li Y
Med Oncol; 2014 Aug; 31(8):103. PubMed ID: 25005846
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.
Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS
Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674
[TBL] [Abstract][Full Text] [Related]
5. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.
Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y
Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390
[TBL] [Abstract][Full Text] [Related]
6. FOXP3 expression in esophageal cancer cells is associated with poor prognosis in esophageal cancer.
Wang G; Liu G; Liu Y; Li X; Su Z
Hepatogastroenterology; 2012 Oct; 59(119):2186-91. PubMed ID: 22389297
[TBL] [Abstract][Full Text] [Related]
7. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
8. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of her-2 associated with the progression of esophageal cancer patients.
Wang G; Zhang W; Jiang W; Luan L
Hepatogastroenterology; 2013; 60(128):1972-8. PubMed ID: 24719937
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of pituitary tumor transforming gene (PTTG) is associated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang J; Yang Y; Chen L; Zheng D; Ma J
Acta Histochem; 2014 Apr; 116(3):435-9. PubMed ID: 24176776
[TBL] [Abstract][Full Text] [Related]
11. Correlation between vascular endothelial growth factor C expression and prognosis in patients with esophageal squamous cell carcinomas after Ivor-Lewis esophagectomy.
Sun ZG; Wang Z; Zhang M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e68-76. PubMed ID: 22897688
[TBL] [Abstract][Full Text] [Related]
12. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
13. CCR7 and VEGF-C: molecular indicator of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
Song Y; Wang Z; Liu X; Jiang W; Shi M
Ann Surg Oncol; 2012 Oct; 19(11):3606-12. PubMed ID: 22644515
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
15. The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
Kandioler D; Schoppmann SF; Zwrtek R; Kappel S; Wolf B; Mittlböck M; Kührer I; Hejna M; Pluschnig U; Ba-Ssalamah A; Wrba F; Zacherl J
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2280-6. PubMed ID: 25135238
[TBL] [Abstract][Full Text] [Related]
16. Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.
Yang HX; Hou X; Liu QW; Zhang LJ; Liu JG; Lin P; Fu JH
Ann Thorac Surg; 2012 Jun; 93(6):1861-6. PubMed ID: 22551848
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
18. Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis.
Umar M; Upadhyay R; Kumar S; Ghoshal UC; Mittal B
J Gastroenterol Hepatol; 2013 Nov; 28(11):1717-24. PubMed ID: 23869757
[TBL] [Abstract][Full Text] [Related]
19. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]